The mouse models show that there are dose dependent effects of CCN2/CTGF within the anterior eye segment, which acts as a modulator of the homeostatic balance of the TGF-β and BMP signaling pathway, which is disrupted in POAG. Here, TGFB1 is linked to open-angle glaucoma.